Sunshine Biopharma (SBFMW) Competitors $0.22 -0.06 (-21.79%) As of 04/3/2025 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock SBFMW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Does the media refer more to ATNFW or SBFMW? In the previous week, Sunshine Biopharma had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Sunshine Biopharma and 0 mentions for 180 Life Sciences. Sunshine Biopharma's average media sentiment score of 0.41 beat 180 Life Sciences' score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral Sunshine Biopharma Neutral Is ATNFW or SBFMW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Sunshine Biopharma N/A N/A N/A Which has stronger valuation & earnings, ATNFW or SBFMW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ASunshine Biopharma$32.96MN/AN/AN/AN/A Does the MarketBeat Community favor ATNFW or SBFMW? 180 Life Sciences and Sunshine Biopharma both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ASunshine BiopharmaN/AN/A SummarySunshine Biopharma beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Remove Ads Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFMW vs. The Competition Export to ExcelMetricSunshine BiopharmaDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.22B$5.53B$7.50BDividend YieldN/A2.92%4.86%4.05%P/E RatioN/A4.2723.2318.08Price / SalesN/A517.74362.7586.83Price / CashN/A10.2538.1634.64Price / BookN/A6.226.493.99Net IncomeN/A$20.70B$3.21B$247.18M7 Day Performance23.51%-1.31%-4.90%-4.25%1 Month Performance55.94%-3.39%-0.07%-6.87%1 Year Performance131.66%90.24%6.45%-3.73% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMWSunshine BiopharmaN/A$0.25-10.9%N/A+196.0%$0.00$32.96M0.003News CoverageGap UpATNFW180 Life SciencesN/A$0.01-3.4%N/A-18.8%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$9.42+3.6%$30.50+223.8%N/A$0.00N/A0.0018Analyst ForecastGap DownAEHAWAesther Healthcare AcquisitionN/A$0.02+4.2%N/A-91.8%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.10-10.3%N/A+54.6%$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$2.57+8.9%N/A-57.6%$0.00$391.87M0.004Positive NewsGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-42.9%$0.00N/A0.0015BFRIWBiofronteraN/A$0.06-36.2%N/A+107.7%$0.00$37.32M0.0070Positive NewsGap DownBTMDWbioteN/A$0.06flatN/A-86.1%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.09-12.4%N/A-91.6%$0.00N/A0.008Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aardvark Therapeutics Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFMW) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
